MD MBA - Phoenix Biotech President
| PBAXWDelisted Stock | 0.06 0.0001 0.16% |
President
MD MBA is President of Phoenix Biotech Acquisition
| Age | 48 |
| Phone | 215 731 9450 |
| Web | https://www.phoenixbiotechacquisitioncorp.com |
Phoenix Biotech Management Efficiency
The company has return on total asset (ROA) of (0.0255) % which means that it has lost $0.0255 on every $100 spent on assets. This is way below average. Phoenix Biotech's management efficiency ratios could be used to measure how well Phoenix Biotech manages its routine affairs as well as how well it operates its assets and liabilities. Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. The company was incorporated in 2021 and is based in Oakland, California. Phoenix Biotech is traded on NASDAQ Exchange in the United States. Phoenix Biotech Acquisition (PBAXW) is traded on NASDAQ Exchange in USA and employs 4 people.Management Performance
| Return On Asset | -0.0255 |
Phoenix Biotech Acqu Leadership Team
Elected by the shareholders, the Phoenix Biotech's board of directors comprises two types of representatives: Phoenix Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Phoenix. The board's role is to monitor Phoenix Biotech's management team and ensure that shareholders' interests are well served. Phoenix Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Phoenix Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MD MBA, President | ||
| Daniel MBA, Chief Officer | ||
| Christopher MBA, CEO Director | ||
| MBA MBA, Chief Officer |
Phoenix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Phoenix Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0255 | |||
| Number Of Shares Shorted | 9.11 K | |||
| Net Income | (2.52 M) | |||
| Total Debt | 650 K | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.71 M) | |||
| Beta | 0.044 | |||
| Total Asset | 42.37 M | |||
| Retained Earnings | (10.76 M) | |||
| Working Capital | 11.62 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Phoenix Stock
If you are still planning to invest in Phoenix Biotech Acqu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Phoenix Biotech's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |